Australian Health Governance & Compliance

Clinical & Health Governance Disclaimer

Therapeutic Goods Act 1989 & National Health Guidelines Alignment Notice • October 2026 Edition

warning

Emergency Medical Directive • Triple Zero (000) If you or someone in your care experiences severe breathing difficulty, wheezing, throat constriction, tongue swelling, or collapse—particularly following sudden atmospheric thunderstorm fronts or high-pollen weather shifts—call 000 immediately for Australian Emergency Ambulance Services. Do not rely on digital protocols during acute anaphylactic or severe bronchospastic events.

1. Not a Substitute for Medical Advice or Diagnosis

The information, educational protocols, mechanical hygiene blueprints, and aeroallergen calendars provided on this website and within the Hay Fever SOS materials are formulated solely for general health education, non-pharmacological lifestyle hygiene, and preventative aerobiological awareness.

Nothing contained within these publications is intended to diagnose, treat, cure, or prevent any clinical disease, nor does it establish a doctor-patient relationship. You should never disregard professional medical advice from a registered General Practitioner, Clinical Immunologist, or Ear, Nose & Throat (ENT) specialist because of something you have read on this site.

2. Prescription Medications & Allergen Immunotherapy

Do not discontinue, modify, or reduce your prescribed medications—including intranasal corticosteroids, oral antihistamines, asthma preventers (such as ICS/LABA combination inhalers), or sublingual/subcutaneous allergen immunotherapy—without direct consultation and supervision from your prescribing Australian healthcare practitioner.

3. Alignment with National Guidelines & Scientific Sources

Hay Fever SOS references published consensus statements and frameworks from reputable public health bodies, including the Australasian Society of Clinical Immunology and Allergy (ASCIA), the National Asthma Council Australia, healthdirect Australia, and the AusPollen Aerobiology Partnership.

Reference to these organizations indicates educational alignment with peer-reviewed aerobiological science and publicly accessible clinical guidelines. It does not imply direct commercial endorsement, institutional affiliation, or sponsorship of Hay Fever SOS by these statutory or clinical organizations.

4. Individual Variability & Outcome Statement

Environmental aeroallergen sensitivity, mucosal barrier integrity, and individual immune responses vary considerably across individuals and geographical bioregions across Australia. Testimonials and verified reviews shared by protocol members represent individual subjective experiences and should not be construed as guaranteed clinical outcomes for every user.

5. Regulatory Contact

For clinical intelligence references or educational inquiries, contact:
Hay Fever SOS Australia • Aerobiological Advisory Team
Email: clinical@hayfeversos.com / support@hayfeversos.com
Sydney, NSW, Australia